Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CBT-502 |
Trade Name | |
Synonyms | CBT502|CBT 502|TQB2450|TQB 2450|TQB-2450|Benmelstobart |
Drug Descriptions |
CBT-502 is a humanized monoclonal antibody that targets PD-L1 (CD274), potentially leading to antitumor activity (PMID: 35675031). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C156692 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anlotinib + CBT-502 | Anlotinib CBT-502 | 0 | 0 |
CBT-502 | CBT-502 | 0 | 0 |